Rating History for NeuBase Therapeutics (NBSE) by Oppenheimer

More Stocks Rated by Oppenheimer | Latest Ratings for NBSE
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/21/2022 Hartaj Singh Downgrade Perform
(Outperform)		 N/A
(N/A)		 0.29
(0.38)		 31.03% Details